Dealing with the Impact of Ritonavir Polymorphs on the Late Stages of Bulk Drug Process Development
- 21 June 2000
- journal article
- review article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 4 (5), 413-417
- https://doi.org/10.1021/op000023y
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- Reduction of an Enaminone: Synthesis of the Diamino Alcohol Core of RitonavirOrganic Process Research & Development, 1999
- Disappearing PolymorphsAccounts of Chemical Research, 1995
- ABT-538 is a potent inhibitor of human immunodeficiency virus protease and has high oral bioavailability in humans.Proceedings of the National Academy of Sciences, 1995